Abstract

Objective: The objective of the study was to look on the prevalence of six AMR genes (CTX-M, TEM, SHV, NDM-1, OXA-48, and VIM genes) in the province of the Arabian Gulf. We performed a systematic review and meta-analysis of the published studies from the Arabian Gulf countries and analyzed the antimicrobial resistance (AMR) genes pattern present in Klebsiella pneumoniae. 
 Methods: The present study used the Meta-analysis Of Observational Studies in Epidemiology as a guideline for reporting findings. An electronic search was conducted in online databases such as PubMed/MEDLINE, EMBASE, Scopus, Google Scholar, Science Direct, and Web of Science from January 2014 to June 2020 following the inclusion and exclusion criteria. Articles published were included in the study resistance pattern among 2036 isolates were analyzed. These isolates conferred the AMR genes including OXA-48 (n=500), CTX-M (n= 1796), SHV (n=1637), TEM (n=1492), NDM-1 (n=500), and VIM (n=302).
 Results: Of 160 initially searched studies, 28 entries met the inclusion criteria and were subjected to meta-analysis. Critical appraisal of studies or quality assessment revealed a mean quality score was 4.2, with an SD of 1.6. The analysis revealed predominant AMR genes wereOXA-48 followed by CTX-M, SHV, TEM, NDM-1, and VIM in the Arabian Gulf region.
 Conclusion: The Arabian Gulf countries share a high prevalence of OXA-48, CTX-M followed by SHV, TEM, NDM-1, and VIM genes. Antimicrobial-resistant in K. pneumoniae is a threat to public health and this needs strong surveillance to curb this threat.

Highlights

  • Klebsiella is one of the common pathogens causing communityacquired bacterial pneumonia, urinary tract infection, and septicemia in patients

  • An increase in antimicrobial resistance (AMR) in Klebsiella pneumonia isolates is of much concern

  • The high prevalence of OXA-48 in the Arabian Gulf reflects the extensive flow between the countries of the Middle East and endemic countries including Turkey, India, and Pakistan[12]

Read more

Summary

Introduction

Klebsiella is one of the common pathogens causing communityacquired bacterial pneumonia, urinary tract infection, and septicemia in patients. A vast majority of Klebsiella infections are hospital-acquired. Individuals with underlying diseases such as diabetes mellitus or chronic pulmonary obstruction or other immunocompromised states can acquire Klebsiella as a nosocomial infection [1]. Klebsiella has been reported as the second most common cause of bacteremia in patients with burns [3]. It is a challenge to treat Klebsiella clinically. Multidrug resistance is reported in Klebsiella since 1984 [3]. Klebsiella has become resistant to beta-lactam drugs, including cephalosporins and aminoglycosides due to its ability to encode extended-spectrum β-lactamases (ESBLs) and aminoglycoside modifying enzymes [3]. An increase in antimicrobial resistance (AMR) in Klebsiella pneumonia isolates is of much concern

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call